Charles River Laboratories International, Inc. (CRL)

CRL Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020
Cash & Equivalents	194.61	276.77	233.91	241.21	228.42
Short-Term Investments	-	-	-	-	1.02
Cash & Short-Term Investments	194.61	276.77	233.91	241.21	229.45
Cash Growth	-29.69%	18.32%	-3.03%	5.13%	-3.98%
Receivables	720.92	780.38	752.39	642.88	617.74
Inventory	278.54	380.26	255.81	199.15	185.7
Prepaid Expenses	103.21	87.88	89.34	93.54	96.71
Restricted Cash	9.54	5.8	6.19	4.02	3.07
Other Current Assets	96.26	77.58	101.39	93.29	68.46
Total Current Assets	1,403	1,609	1,439	1,274	1,201
Property, Plant & Equipment	2,017	2,034	1,857	1,584	1,303
Long-Term Investments	218.35	243.81	311.6	201.35	221.8
Goodwill	2,847	3,095	2,850	2,712	1,809
Other Intangible Assets	723.4	864.05	955.28	1,061	787.6
Long-Term Deferred Tax Assets	42.18	40.28	41.26	40.23	37.73
Other Long-Term Assets	278.23	309.38	148.28	151.54	130.82
Total Assets	7,528	8,195	7,603	7,024	5,491
Accounts Payable	140.34	168.94	205.92	198.13	122.48
Accrued Expenses	386.43	441.12	403.41	474.92	356.64
Current Portion of Long-Term Debt	0.16	3.17	1.35	0.1	47.2
Current Portion of Leases	56.93	57.31	48.86	35.96	27.69
Current Income Taxes Payable	31.9	38.8	39.9	26.2	24.88
Current Unearned Revenue	337.77	327.37	355.9	279.22	250.19
Other Current Liabilities	40.58	18.38	36.26	18.66	10.68
Total Current Liabilities	994.1	1,055	1,092	1,033	839.75
Long-Term Debt	2,215	2,621	2,681	2,639	1,904
Long-Term Leases	509.46	445.39	418.06	277.5	181.62
Long-Term Unearned Revenue	34.29	30.92	25.8	20.58	19.48
Long-Term Deferred Tax Liabilities	106.96	191.35	215.58	239.72	217.03
Other Long-Term Liabilities	160.92	192.27	147.5	222.28	111.51
Total Liabilities	4,020	4,536	4,579	4,432	3,347
Common Stock	0.51	0.51	0.51	0.51	0.5
Additional Paid-In Capital	1,966	1,906	1,805	1,718	1,628
Retained Earnings	1,812	1,887	1,433	980.75	625.41
Comprehensive Income & Other	-317.35	-196.43	-262.06	-164.74	-138.87
Total Common Equity	3,462	3,597	2,976	2,535	2,115
Minority Interest	46.58	62.12	47.21	57.17	29.07
Shareholders' Equity	3,508	3,659	3,024	2,592	2,144
Total Liabilities & Equity	7,528	8,195	7,603	7,024	5,491
Total Debt	2,781	3,127	3,149	2,953	2,160
Net Cash (Debt)	-2,586	-2,850	-2,915	-2,711	-1,931
Net Cash Per Share	-50.10	-55.39	-56.82	-52.73	-38.15
Filing Date Shares Outstanding	51.14	51.35	50.99	50.49	49.78
Total Common Shares Outstanding	51.14	51.34	50.94	50.48	49.77
Working Capital	408.97	553.58	347.45	240.91	361.38
Book Value Per Share	67.69	70.06	58.42	50.21	42.49
Tangible Book Value	-108.51	-362.21	-828.89	-1,238	-482.17
Tangible Book Value Per Share	-2.12	-7.06	-16.27	-24.53	-9.69
Land	71.74	79.55	58.19	59.49	61.03
Buildings	1,070	1,054	963.72	987.54	1,060
Machinery	1,335	1,277	1,111	1,000	892.39
Construction In Progress	143.31	197.72	199.71	205.14	92.33
Leasehold Improvements	438.75	366.56	294.28	141.53	104.97
Order Backlog	2,788	3,132	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.